Rafarma Has Officially Begun Research Programs with Khon Kaen University in Thailand
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is pleased to inform its shareholders that the previously-announced specialized research...
top of page
Поиск
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is moving forward with its research initiatives for medicinal cannabis in Thailand. The...
Rafarma – MTP Partnership to Open Specialized Spas Offering Cannabis Treatments in Thailand
Following on the recently-announced partnership between Rafarma Pharmaceuticals Inc. (OTC: RAFA), and Thailand’s MTP Material Co. Ltd.,...
Rafarma Closes Exclusive Joint Venture Contract with Thailand Cannabis Partner
Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL...
Rafarma Adds Thai Corporate Officer to Solidify Market Entry in Thailand Cannabis Industry
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is pleased to welcome a new Executive Vice-President for Thai operations, Mr. Anucha Phetpheng....
Rafarma Announces the Cancellation of All Outstanding Preferred A Shares
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) announces the cancellation of all outstanding Preferred Class A shares. On August 28th, 2019,...
Rafarma to Commence Production in Thailand; Predicted to Be The Region’s “Cannabis Capital”
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is positioning to expand its operations in the “next big thing” in cannabis production —...
Rafarma’s Agri-Tech Keeping Cannabis Production “High”
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is continuing to actively promote its hemp oil products in the European market. Despite the...
Rafarma Pharmaceuticals Welcomes New CEO Vladimir Dolgolenko
Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo...
Rafarma’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis
Rafarma Pharmaceuticals, Inc. (OTC: RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of...
Rafarma Pharmaceuticals Adds Blockchain Tech to Cannabis Distribution
Rafarma Pharmaceuticals, Inc. (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of...
Rafarma Announces Acquisition of Aeroponic Technology Expecting to Quadruple Production
Rafarma Pharmaceuticals (OTC: RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition...
Rafarma: Now “Growing” More Than Ever!
Rafarma Pharmaceuticals, Inc. (OTC: RAFA), a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis...
Rafarma Joins with Glorija Kotnik to New Victories
Rafarma (OTC: RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its...
Rafarma Pharmaceuticals, Inc. acquires Dartis D.O.O. and Ekopostopek D.O.O.
Rafarma (OTC: RAFA), a Wyoming Corporation, acquires Dartis D.O.O. and Ekopostopek D.O.O., Slovenian- based developers and manufacturers...
Rafarma Pharmaceuticals announces the resignation of David Jones from all positions at the company
Management of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) announces the resignation of David Jones from all positions at the company....
Rafarma Pharmaceuticals announces European approval and corrections
New Management of RAFARMA PHARMACEUTICALS, INC. (OTC: RAFA) is proud to announce that on December 19, 2014 “ZAO Rafarma” was awarded...
Rafarma Pharmaceuticals announces new president
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director...
Rafarma Pharmaceuticals commences preparation of audited financials
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) has commenced a formal audit to provide additional transparency in its public filings with a...
Rafarma Pharmaceuticals announces significant cash flow improvement through restructuring
In response to shareholder inquiries, CEO Dave Anderson offers further comment on the improved financial position of Rafarma: "Due to the...
bottom of page